NEW YORK (GenomeWeb News) – The University of South Florida will use a $2.8 million grant from the National Institutes of Health to partner with Aetna and patient advocates to study how genetic testing for breast cancer risk can impact clinical decisions made by patients and doctors.

USF said today that the five-year American BRCA Outcomes Among Recently Diagnosed (ABOARD) study could fill a gap in knowledge about how breast cancer risk tests are being used and could guide policies and services to help patients and doctors make better health decisions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: factors affecting the success of whole-genome sequencing for routine clinical diagnosis, and more.

A large meta-analysis from an international team reports that nature and nurture have about an equal overall influence on human traits.

The Lasker Foundation's Claire Pomeroy laments the state of NIH funding at Forbes.

Social media is changing how scientists discuss research, as tweets from University of Chicago's Yoav Gilad about a Mouse ENCODE paper have shown, Nature reports.